OPKO Health | OPK - Sales Revenues

Stock Price
455.90
Daily Change
1.60 0.35%
Monthly
6.32%
Yearly
-22.33%
Q3 Forecast
457.27

OPKO Health reported $156.81M in Sales Revenues for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 1.97B
Cash and Equivalent USD 267.28M
Cost of Sales USD 137.75M
Current Assets USD 583.33M
Current Liabilities USD 171.18M
Debt USD 395.74M
EBIT USD -92.19M
EBITDA USD -69.17M
Employees USD 3.93K
EPS Earnings Per Share USD -0.19
Equity Capital and Reserves USD 1.3B
Gross Profit on Sales USD 19.06M
Interest Expense on Debt USD 70.33M
Interest Income USD 3.29M
Loan Capital USD 332.94M
Market Capitalization USD 3.18B
Net Income USD -148.44M
Operating Expenses USD 216.79M
Operating Profit USD -59.98M
Ordinary Share Capital USD 779.78M
PE Price to Earnings USD 40.77
Pre-Tax Profit USD -162.52M
Sales Revenues USD 156.81M
Selling and Administration Expenses USD 59.6M
Stock USD 66.34M
Trade Creditors USD 56.68M
Trade Debtors USD 110.19M

Sales Change Date
Alcidion AUD 17.64M 8.64M Dec/2024
Ambu A/S DKK 1.51B 40M Jun/2025
Amplifon EUR 592.85M 4.95M Jun/2025
Apollo Hospitals Enterprise Ltd 57.5B 1.61B Jun/2025
Convatec Group 1.18B 0 Jun/2025
Diasorin EUR 306M 7M Jun/2025
Gulf Medical Proj AED 180.05M 8.28M Mar/2025
Ionis Pharmaceuticals USD 452M 320M Jun/2025
Med Life RON 736.79M 68.5M Dec/2024
OPKO Health USD 156.81M 26.79M Jun/2025
Oriola-kd EUR 493.9M 53.2M Jun/2025
Rede D'or Sao Luiz BRL 14.12B 440M Jun/2025
Siemens Healthineers EUR 5.66B 250M Jun/2025
Sonova Holding CHF 1.83B 40.7M Sep/2024
Supermax Corporation Bhd MYR 154.74M 44.04M Jun/2025